Agentic AI
AGENTIC AI
Achieve new levels of efficiency and automation
With IQVIA AI, we can deploy AI agents to automate tasks or complex processes at scale, enabling you to do more with less. Our AI is trained and guided by industry experts to leverage insights and intelligence that increase your organizational capacity and free up resources so you can focus on what matters most to your business.
AGENTIC AI
How we engineer AI agents specifically for life sciences
IQVIA AI can deliver agentic capabilities seamlessly integrated with your environment, featuring intuitive user interfaces, agentic workflows, and enabling humans in the loop. Using the latest industry standards, our AI infrastructure enables instant asset discovery and APIs for flexibility. And with NVIDIA’s data flywheel technology, it grows smarter with every action—transforming legacy systems into a streamlined, intelligent journey for life sciences.
Our vision for agentic AI
Unleash productivity with agentic AI
PODCAST
How Agentic AI shortens drug development and improves patient outcomes
Agentic AI is transforming life sciences—accelerating clinical trials, improving patient engagement, and reshaping how therapies reach those who need them. In this NVIDIA AI podcast, hear IQVIA’s Raja Shankar and Avinob Roy share how AI delivers faster results and better care.
BLOG
How Emerging AI Capabilities are Reshaping Life Sciences
As the industry expands from using traditional AI to deploying autonomous agents, the transformational possibilities for life sciences are accelerating.
Agentic AI FAQ
How it can help you achieve your goals
Agentic AI refers to autonomous AI systems that can independently perform tasks, make decisions, and interact with their environment without constant human supervision. Unlike traditional AI, which often requires human input to generate output, agentic AI can autonomously devise plans, set goals, adapt, and execute strategies on its own.
Agentic AI will further enhance and speed processes related to clinical trials, drug development, and regulatory compliance. It can optimize patient enrollment, monitor real-time data, flag compliance issues, and suggest corrective actions, thereby improving efficiency and accuracy. Going forward, agentic AI will be increasingly capable of predicting probabilty of success as well as sophisciated simulation algorithms to help optimize end-to-end development.
Potential challenges include integrating agentic AI into existing systems, ensuring data privacy and security, mitigating bias, regulatory compliance, and managing the quality and ethical implications of autonomous decision-making. Companies need a clear AI strategy, s systematic approach to enterprise architecture, and human experts in the loop to successfully adopt agentic AI.
AI agents can be designed to act on your behalf, handling time-consuming tasks like literature reviews, data analysis, real-time insights generation, and so much more. By automating tasks, AI agents can free up human teams to focus on high-priority work—enabling them to get more done, faster.
Agentic AI is being used across the entire asset lifecycle, from increasing speed and efficiency of clinical trial start up, to automating literature reviews, to combining a variety of data sources to better prepare field sales for high quality conversations with healthcare providers. Agentic AI is also proving to be beneficial for process automation in general, which can boost efficiency or otherwise streamline processes across life sciences operations.
White Paper
Promising New Developments in Artificial Intelligence
Innovating with generative and agentic AI to drive efficiency and quality in clinical trials
AI you can trust
IQVIA Healthcare-grade AI® is AI engineered to meet the unique needs of life sciences and healthcare. It’s what you get when we bring together unparalleled data, expertise, and the latest technologies. So you get answers and insights you can trust, faster.
